Desmopressin
Desmopressin is a pharmaceutical drug with 48 clinical trials. Currently 3 active trials ongoing. Historical success rate of 80.6%.
Success Metrics
Based on 29 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
7
Mid Stage
23
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.4%
29 of 37 finished
21.6%
8 ended early
3
trials recruiting
48
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
Desmopressin for Bedwetting in Children With SCD
Clinical Trials (48)
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
Desmopressin for Bedwetting in Children With SCD
Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.
Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
Study on Chinese and Western Medicine in MNE Children
Study of Minirin Melt® in Adult Patients With Nocturia
Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 48